Calcium Stones (~70–80%)
Calcium stones are the most common renal stones. They form when calcium combines with oxalate or phosphate in urine.
Calcium oxalate (~60-70%)
Most common stone type overall. Associated with low urine volume, hypercalciuria, hyperoxaluria, and hypocitraturia. Can form across a wide urine pH range. Often recurrent, generally responsive to ESWL. Prevention focuses on hydration, dietary sodium and oxalate reduction, and increased citrate intake where indicated.
Calcium phosphate (~10-15%)
Form preferentially in alkaline urine. Suggest abnormalities of urinary acidification.
Subtypes include: Carbonate apatite (~8-12%): more common, often infection-associated, moderate hardness; Brushite (~1-2%): hard, dense, recurrent, poor ESWL response. Associated with distal (Type 1) renal tubular acidosis, hypercalciuria, and carbonic anhydrase inhibitors (e.g. topiramate).
Uric Acid Stones (~10%)
The only common stone type that can be treated without surgery. Form in persistently acidic urine. Associated with gout, metabolic syndrome, chronic diarrhoea, and low urine volume. Radiolucent on plain X-ray, visible on CT. Can dissolve with sustained urine alkalinisation.
Infection (Struvite) Stones (~5-10%)
Stones caused by infection rather than metabolic imbalance. Form in alkaline urine due to urease-producing bacteria. Grow rapidly and may form staghorn calculi. Act as a reservoir for infection. More common in women, chronic infections, neurogenic bladder.
👉 Antibiotics alone are insufficient; complete surgical clearance is required.
Cystine Stones (Rare) (~1-2%)
Caused by inherited cystinuria. Present early in life. Highly recurrent and often ESWL-resistant.
👉 Lifelong condition requiring specialist follow-up.
Other and Uncommon Stone Types
Drug-related stones: Direct crystallisation (indinavir, atazanavir, triamterene, sulfonamides) Drug-induced metabolic effects (topiramate, acetazolamide → alkaline urine, hypocitraturia → ↑ calcium phosphate stones).
Matrix stones: Soft, protein-rich, poorly calcified, often associated with chronic infection or catheters.
Rare metabolic stones: Xanthine stones (xanthinuria), 2,8-dihydroxyadenine stones (APRT deficiency; risk of progressive renal impairment, respond to allopurinol).
👉 Always review medication history in recurrent or atypical stone disease.